Novartis partners with Microsoft to use AI in drug development - STAT

Novartis partners with Microsoft to use AI in drug development - STAT

STAT Plus: Novartis partners with Microsoft to use AI in drug development

By REBECCA ROBBINS

JOHANNES EISELE/AFP/GETTY IMAGES

Novartis and Microsoft will use artificial intelligence to design molecules, personalize medication dosing, and optimize the manufacture of cancer therapy.

READ MORE